Protheragen-ING

Protheragen-ING logo

Protheragen-ING is engaged in the introduction of various chemical products to the global market, including active pharmaceutical ingredients (APIs), pharmaceutical excipients, veterinary chemicals, membrane materials, packaging materials. We are also a solution provider for chemistry-related analysis services.

Company Website

Product Listing

D-ribose inquiry  | 0.98%

Protheragen-ING

D-Ribose is produced by microorganism fermentation of glucose in a fermentation culture medium without adding calcium carbonate.

More Information Supplier Page

D-Tryptophan inquiry  | Purity Not Available

Protheragen-ING

Tryptophan is one of the 20 standard amino acids, as well as an essential amino acid in the human diet. It is encoded in the standard genetic code as the codon UGG. The D-stereoisomer is occasionally found in naturally produced peptides (for example, the marine venom peptide contryphan). The distinguishing structural characteristic of tryptophan is […]

More Information Supplier Page

D(-)-Penicillamine inquiry  | Purity Not Available

Protheragen-ING

D-penicillamine is an optically active form of penicillamine having D-configuration. Pharmaceutical form (L-form is toxic) of chelating agent used to treat heavy metal poisoning. It has a role as a chelator, an antirheumatic drug, a drug allergen and a copper chelator. It is a penicillamine and a non-proteinogenic alpha-amino acid. It is an enantiomer of […]

More Information Supplier Page

D(+)-Galactose(originated from milk) inquiry  | Purity Not Available

Protheragen-ING

Galactose has been used in trials studying the treatment and diagnosis of Hepatitis C, Hepatic Cancer, Wilsons Disease, Diabetic Macular Oedema, and Focal Segmental Glomerulosclerosis, among others. There are even proposals for its use in accelerating senescence in mice, rats, and Drosophila, for its association with ovarian cancer, or even for the potential treatment of […]

More Information Supplier Page

D(+)-Galactose(originated from plants) inquiry  | Purity Not Available

Protheragen-ING

Galactose has been used in trials studying the treatment and diagnosis of Hepatitis C, Hepatic Cancer, Wilsons Disease, Diabetic Macular Oedema, and Focal Segmental Glomerulosclerosis, among others. There are even proposals for its use in accelerating senescence in mice, rats, and Drosophila, for its association with ovarian cancer, or even for the potential treatment of […]

More Information Supplier Page

D(+)-Glucose inquiry  | Purity Not Available

Protheragen-ING

It is produced in humans via hepatic gluconeogenesis and breakdown of polymeric glucose forms (glycogenolysis). It circulates in human circulation as blood glucose and acts as an essential energy source for many organisms through aerobic or anaerobic respiration and fermentation. It is primarily stored as starch in plants and glycogen in animals to be used […]

More Information Supplier Page

D(+)-Glucose inquiry  | 0.98%

Protheragen-ING

Aldehydo-D-glucose is the open chain form of D-glucose. It is a D-glucose and an aldehydo-glucose. It is an enantiomer of an aldehydo-L-glucose.

More Information Supplier Page

Dabigatran Etexilate inquiry  | Purity Not Available

Protheragen-ING

A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.

More Information Supplier Page

Dabrafenib mesylate inquiry  | Purity Not Available

Protheragen-ING

Used for treatment of metastatic melanoma. It has a role as an antineoplastic agent and a B-Raf inhibitor. It contains a dabrafenib.

More Information Supplier Page

Dacomitinib inquiry  | Purity Not Available

Protheragen-ING

Dacomitinib is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively.

More Information Supplier Page

Dacomitinib inquiry  | Purity Not Available

Protheragen-ING

Dacomitinib is a highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with potential antineoplastic activity.

More Information Supplier Page

Daidzin inquiry  | Purity Not Available

Protheragen-ING

Daidzein 7-O-beta-D-glucoside is a glycosyloxyisoflavone that is daidzein attached to a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It is used in the treatment of alcohol dependency (antidipsotropic). It has a role as a plant metabolite. It is a hydroxyisoflavone, a monosaccharide derivative and a 7-hydroxyisoflavones 7-O-beta-D-glucoside. It is functionally related to a […]

More Information Supplier Page

Dalbavancin inquiry  | Purity Not Available

Protheragen-ING

Dalbavancin is a semisynthetic glycopeptide used for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA. It has a role as an antibacterial drug and an antimicrobial agent. It is a carbohydrate acid derivative, a monosaccharide derivative, a glycopeptide […]

More Information Supplier Page

Dalteparin Sodium inquiry  | Purity Not Available

Protheragen-ING

Dalteparin Sodium is the sodium salt of a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, dalteparin binds to antithrombin and enhances the inhibition of Factor Xa. Compared to unfractionated heparins, the use of dalteparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia.

More Information Supplier Page

dAMP. Na2 inquiry  | Purity Not Available

Protheragen-ING

It displays its profound potential as a nucleotide analogue, contributing extensively to the management of diverse ailments such as viral infections and select malignancies. With improved stability and solubility attributed to its disodium salt form, this compound emerges as an optimal preference within the biomedical realm, particularly for research and pharmaceutical purposes.

More Information Supplier Page

dAMP.H2 inquiry  | Purity Not Available

Protheragen-ING

It has a role as a fundamental metabolite. It is a purine 2′-deoxyribonucleoside 5′-monophosphate and a 2′-deoxyadenosine 5′-phosphate. It is a conjugate acid of a 2′-deoxyadenosine 5′-monophosphate(2-).

More Information Supplier Page

Danshensu inquiry  | 0.98%

Protheragen-ING

Danshensu is an active component of Salvia miltiorrhiza that shows wide cardiovascular benefit. It suppresses the formation of reactive oxygen species and inhibits platelet adhesion and aggregation. It also protects myocardium from the reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation. It increases production of collagenin Detroit 551 cells and […]

More Information Supplier Page

Dapagliflozin inquiry  | Purity Not Available

Protheragen-ING

Used (in the form of its propanediol monohydrate) to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. It has a role as a hypoglycemic agent and a sodium-glucose transport protein subtype 2 inhibitor.

More Information Supplier Page

Dapagliflozin Propanediol Monohydrate inquiry  | Purity Not Available

Protheragen-ING

Dapagliflozin (2S)-1,2-propanediol, hydrate is the S-enantiomer of Dapagliflozin 1,2-propanediol, hydrate. Dapagliflozin inhibits sodium/glucose cotransporter 2 (SGLT2), which results in excretion of glucose into the urine.

More Information Supplier Page

Daptomycin inquiry  | Purity Not Available

Protheragen-ING

Daptomycin is an intravenously administered, broad spectrum antibiotic used to treat complex skin and tissue infections, endocarditis and bacteremia. Daptomycin is associated with a low to modest rate of serum enzyme elevations during therapy, but is a very rare cause of clinically apparent liver injury.

More Information Supplier Page

Dasatinib inquiry  | Purity Not Available

Protheragen-ING

A multi-targeted kinase inhibitor, it is used, particularly as the monohydrate, for the treatment of chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia.

More Information Supplier Page

Dasatinib Monohydrate inquiry  | Purity Not Available

Protheragen-ING

A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.

More Information Supplier Page

Dasiglucagon inquiry  | Purity Not Available

Protheragen-ING

Dasiglucagon acetate is a glucagon analog for diabetic hypoglycemic treatment, which has a higher absorption rate and longer plasma elimination half-life than conventional reconstituted glucagon.

More Information Supplier Page

dATP inquiry  | Purity Not Available

Protheragen-ING

DATP is a purine 2′-deoxyribonucleoside 5′-triphosphate having adenine as the nucleobase. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a purine 2′-deoxyribonucleoside 5′-triphosphate and a 2′-deoxyadenosine 5′-phosphate. It is a conjugate acid of a dATP(3-).

More Information Supplier Page

dATP trisodium salt inquiry  | Purity Not Available

Protheragen-ING

This compound serves as a pivotal cog in DNA and RNA synthesis. Its function transcends mere chemical reactions, as it diligently enables the intricate transfer of genetic information within cellular metabolism. Furthermore, its intricate involvement extends to the therapeutic landscape, where it exhibits formidable potential in combating viral infections, metabolic aberrations, and select cancer subtypes.

More Information Supplier Page

Davephos PD G3 inquiry  | Purity Not Available

Protheragen-ING

Davephos PD G3 is used as a Buchwald coupling reaction catalyst and could be used in the Suzuki coupling reaction.

More Information Supplier Page

dCMP.H2 inquiry  | Purity Not Available

Protheragen-ING

It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a 2′-deoxycytidine phosphate and a pyrimidine 2′-deoxyribonucleoside 5′-monophosphate. It is a conjugate acid of a 2′-deoxycytosine 5′-monophosphate(2-). It is an enantiomer of a 2-deoxy-5-O-phosphono-beta-L-ribofuranosylcytosine.

More Information Supplier Page

dCMP.Na2 inquiry  | Purity Not Available

Protheragen-ING

2′-Deoxycytidine-5′-monophosphate disodium salt, a crucial component in the biomedical field, exhibits immense significance in both research and pharmaceutical advancements. With its extensive utilization in DNA synthesis and repair, this compound plays a pivotal role in the exploration of genetic disorders and the development of innovative therapeutic approaches for ailments like cancer.

More Information Supplier Page

dCTP inquiry  | Purity Not Available

Protheragen-ING

A metabolite of 2′-Deoxycytidine. A nucleoside triphosphate that is used whenever DNA is synthesized, such as in the polymerase chain reaction.

More Information Supplier Page

Decitabine inquiry  | Purity Not Available

Protheragen-ING

Decitabine is a potent inhibitor of DNA methylation, used to treat myelodysplastic syndrome (MDS).

More Information Supplier Page

Decitabine Intermediate CR inquiry  | Purity Not Available

Protheragen-ING

4-Amino-1-[3,5-bis-O-(4-chlorobenzoyl)-2-deoxy-β-D-erythro-pentofuranosyl]-1,3,5-triazin-2(1H)-one is a derivative of β-Decitabine which is used as cancer treatment, in particular to inhibit the growth of pancreatic endocrine tumor cell lines.

More Information Supplier Page

Decoquinate inquiry  | Purity Not Available

Protheragen-ING

Decoquinate is used in veterinary to delay the growth and reproduction of coccidian parasites.

More Information Supplier Page